Le Lézard
Classified in: Health
Subject: PER

Proton Therapy Partners Welcomes New Member to Board of Directors


PHILADELPHIA, Dec. 6, 2019 /PRNewswire/ -- Proton Therapy Partners (PTP) is pleased to announce the addition of David L. Bernd to its Board of Directors. 

(PRNewsfoto/Proton Therapy Partners)

"It's an honor to welcome David to our Board of Directors," says Chris Dadlez, CEO of PTP. "David is a respected leader and innovator in the healthcare industry and will be a tremendous asset to PTP as we work to achieve our mission of improving outcomes, changing lives ?.  David possesses vast industry knowledge and experience that will help to strengthen and grow PTP nationally."

For more than 20 years, David L. Bernd served as the Chief Executive Officer of Sentara Healthcare, a $5.2 billion integrated health system headquartered in Norfolk, Va., comprised of 12 acute-care hospitals, with health plans covering 450,000 lives, 950+ provider medical groups and medical staffs of approximately 3,700 physicians. Under his leadership, Sentara developed a national reputation for safety, quality, and innovation, and Sentara facilities and programs have been recognized in the America's Best Hospitals rankings by U.S. News & World Report for the past 15 years. Mr. Bernd led the organization into a new era of health care, caring for defined populations and transforming the way health care is provided.  Mr. Bernd was recognized for his commitment to information technology with the 2010 CEO IT Achievement Award by Modern Healthcare.

Mr. Bernd was named by the U.S. Secretary of Commerce to serve as a member of the Measuring Innovation in the 21st Century Economy Advisory Committee of the Department of Commerce in 2006- 2007. He was Chair of the VHHA Board of Directors from November 1994-October 1995, and in 2004, Mr. Bernd served as chairman of the American Hospital Association Board of Trustees, making him the top elected official of the largest hospital and health system association in the United States.

Mr. Bernd serves on the Board of Visitors at Old Dominion University and served as Rector from 2010 ? 2012. In addition, he has served on the VHA, Inc. Board of Directors. In October 2014 Mr. Bernd was appointed by the Secretary of the Army as a Civilian Aide. He is past Chairman of the United Way of South Hampton Roads Board of Directors and the Metropolitan Board of YMCA of South Hampton Roads.

About Proton Therapy Partners (protontherapypartners.com)  
Proton Therapy Partners (PTP) is an innovative healthcare services company that offers a proven equity joint venture model to provide health systems with access to proton therapy at a lower cost and with a smaller footprint. Its internationally recognized executive and medical team understands the multiple complexities that come with building a proton therapy center and leverages its deep experience to provide a turn-key solution that includes overall project management, education and training. PTP's proven track record of success cuts across a variety of settings, including health systems, academic medical centers, comprehensive cancer centers, and community-based providers. PTP is a portfolio company of Concord Health Partners.

CONTACT: Nanci Gage, 770.845.4629, ngage@ptpnow.org

SOURCE Proton Therapy Partners


These press releases may also interest you

at 20:12
The food recall warning issued on August 1, 2020 has been updated to include additional distribution information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation. Industry is...

at 19:16
Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative...

at 19:15
The "Syringe and Needle Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global syringe and needle market is expected to grow at a CAGR of over 10% during the period 2019-2025 The global...

at 19:00
The "US Acne & Rosacea Market: Insights, Trends & Forecast (2020-2024)" report has been added to ResearchAndMarkets.com's offering. The US acne market is expected to reach US$4.49 billion in 2024, recording growth at a CAGR of 4.12% during the period...

at 18:15
The "Coronavirus Disease 2019 (COVID-19) - Analysis of the Emerging Disease Landscape - June 2020" report has been added to ResearchAndMarkets.com's offering. The Epidemiology of COVID-19 is rapidly evolving and a number of companies have begun to...

at 18:10
Service Corporation International (the "Company") announces that the previously announced cash tender offer for any and all of its 5.375% Senior Notes due 2024 (CUSIP No. 817565 CB8/ ISIN No. US817565CB82) (the "Notes"), which expired today at 5:00...



News published on 6 december 2019 at 13:14 and distributed by: